- In December 2020, LATAM made the free transport of the doses available to the authorities of the countries where it has domestic operations.
- To date, the group has transported over 23.7 million vaccines in more than 50 localities domestically in Brazil, Chile, Ecuador, and Peru on more than 300 flights.
LATAM Airlines Group reported today that it will continue to transport vaccines at no cost within the countries where it operates throughout 2021 through its Solidarity Plane program. To date, the group has transported over 23.7 million vaccines against COVID-19 within South America, through more than 300 flights in the domestic markets of Brazil, Chile, Ecuador, and Peru.
More than 50 towns have benefited from the doses, including those located in difficult access points including Easter Island in Chile, Galapagos in Ecuador, Iquitos in Peru. In Brazil, doses have been moved to all states, as a result of the country’s current health crisis.
After the arrival of the first shipments of vaccines to the region in December 2020, LATAM made the free transport of doses available to the authorities of the governments of the countries where it has domestic operations.
Since the beginning of the pandemic to date, Solidarity Plane has transported more than 480 tons of medical supplies, benefiting Argentina, Brazil, Chile, Colombia, Ecuador, and Peru. At the same time, more than 1.400 organs and tissues were mobilized within South America and the transfer of stem cells was carried out for ten people with blood cancer, who were able to receive a second chance at life. In passenger transport, more than 1.300 health professionals were able to travel to meet different needs related to Covid-19 in the countries that LATAM operates with domestic flights.
Through LATAM Cargo, the group has transported over 48 million vaccines to South America and within the countries in which it operates. LATAM Cargo is the first airline in the American continent, and the only one in the region, to obtain the CEIV Pharma (IATA) certification. This voluntary certificate internationally certifies that facilities, equipment, operations, and personnel meet all applicable standards, regulations, and guidelines expected by pharmaceutical manufacturers.
